Research article · 17 Jul 2026
Conference abstractPublished 12 Nov 2013
Quality assurance on a budget: A non commercial perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The Research Governance Framework and the Medicines for Human Use (Clinical Trials) Regulations both state that NHS organisations should have defined processes in place in order to ensure the quality of studies being conducted within their institutions. The Department of Health considers research a priority and provides around £1 billion a year to fund research. This is additional to money granted by public bodies such as the Medical Research Council. So NHS trusts must increasingly be able to demonstrate robust Quality Assurance (QA) systems in return for this investment. But there is a growing need to ensure that the systems in place make most of a limited budget. This presentation will suggest methods to ensure quality assurance on a budget from a non-commercial perspective. The Medicines and Healthcare products Regulatory Agency (MHRA) advocates a risk based approach to monitoring studies and this can be transposed into QA systems. For example, self-monitoring of low risk studies can reduce costs and allow trial monitors to focus on higher risk studies and by performing trend analysis on audit reports, training sessions can be arranged on a particular topic for an organisation if there are similar findings across a number of studies. By focusing more closely on mitigating high risk factors across a study or organisation, a higher level of QA is ensured.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Developing Drugs.
Commentary · 4 Feb 2026
Vaccine Development and Global Disease Prevention
Commentary · 4 Feb 2026
Transforming Drug Development Through Pharmaceutical Biotechnology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Developing Drugs
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Lucy H. H. Parker”
